Paratek Pharmaceuticals Inc note 4.750% 5/0 shares owned by Athyrium Capital Management
Quarter-by-quarter ownership of Paratek Pharmaceuticals Inc note 4.750% 5/0 shares owned by Athyrium Capital Management
from 13F filings
Historical chart of Athyrium Capital Management investment in Paratek Pharmaceuticals Inc note 4.750% 5/0
Tip: Access up to 7 years of quarterly data
All positions including Paratek Pharmaceuticals Inc note 4.750% 5/0 held by Athyrium Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Paratek Pharmaceuticals Inc note 4.750% 5/0 by Athyrium Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $8.8M | 9.0M | 0.98 |
| 2023-03-31 | $0 | 0 | 0.00 |
| 2022-12-31 | $8.2M | 9.0M | 0.91 |
| 2022-09-30 | $8.0M | 9.0M | 0.89 |
| 2022-06-30 | $7.9M | 9.0M | 0.87 |
More positions owned by Athyrium Capital Management
View all positions for Athyrium Capital Management